Differing opinions about the Lambda variant: Super mutant, successor to Delta or damp squib? For the first time since the SARS-CoV-2 Task Force was established 18 months ago, a difference of opinion has arisen, specifically with regard to the Lambda variant. What everyone agrees on is that the Lambda or C.37 variant is clearly more…
Read More
The skepticism of Dr Robert Hess regarding the efficacy of all previous vaccines against the Delta variant has been confirmed by the announcement from BioNTech/Pfizer that they are working on a vaccine that will specifically target this mutant. The Delta variant of the novel coronavirus, which is causing concern across the whole of Europe, is…
Read More
The SARS-CoV-2 T-Cell immunity analysis is to be integrated into our Covid-19 Immunization Program for clients with immediate effect. So far, we have been testing only one of the two immunity pillars, namely antibody production. In addition to checking the full range of antibodies, Dr Robert Hess goes far beyond the generally applied classification to…
Read More
The SARS-CoV-2 T-Cell immunity analysis is to be integrated into the Covid-19 Immunization Program for Dr Robert Hess clients with immediate effect. So far, we have been testing only one of the two immunity pillars, namely antibody production. In addition to checking the full range of antibodies, we go far beyond the generally applied classification…
Read More
CureVac was the great hope of Dr Robert Hess. They reached for the stars – and came back down with a bump. Though the news was not entirely unexpected, we regret to report that the breakthrough vaccine promised by CureVac will now not be forthcoming. There are a number of reasons for this, but the…
Read More
How long does the protection afforded by vaccination last? This is a vital question that can only be answered when enough time has elapsed for results to come in. There is one thing we can be certain of, however, namely that the protection afforded by vaccines does not live up to the claims made by…
Read More